📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanoma. (2021)

First Author: Peri A

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1172/jci129466

PubMed Identifier: 34651586

Publication URI: http://europepmc.org/abstract/MED/34651586

Type: Journal Article/Review

Volume: 131

Parent Publication: The Journal of clinical investigation

Issue: 20

ISSN: 0021-9738